Moreover, Lattouf H. et al. found that LKB1-mediated phosphorylation of PRMT5 promotes its interaction with MEP50, pICln, and RioK1, leading to PRMT5 activation in breast cancer cells [40]. Here, PRMT5 is linked to breast cancer.